These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 20882676)

  • 21. Drug utilization patterns and healthcare resource use and costs in patients with neurogenic bladder in the United Kingdom: A retrospective primary care database study.
    Jaggi A; Nazir J; Fatoye F; Siddiqui E; Choudhury N; Argoubi R; Ali M; de Ridder D; Drake MJ
    Neurourol Urodyn; 2019 Jun; 38(5):1278-1289. PubMed ID: 30924184
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Drug coverage for Medicare beneficiaries: why protection may be in jeopardy.
    Briesacher B; Stuart B; Shea D
    Issue Brief (Commonw Fund); 2002 Jan; (505):1-8. PubMed ID: 11922051
    [No Abstract]   [Full Text] [Related]  

  • 23. [Neurogenic bladder disturbances--who is to treat and follow-up the patients?].
    Andersen JT; Nordenbo AM; Lose G; Walter S
    Ugeskr Laeger; 2001 Nov; 163(48):6774-6. PubMed ID: 11768911
    [No Abstract]   [Full Text] [Related]  

  • 24. Detrusor instability--an overview.
    Kao LW
    J Tenn Med Assoc; 1994 Nov; 87(11):472-4. PubMed ID: 7983862
    [No Abstract]   [Full Text] [Related]  

  • 25. Burden of chronic obstructive pulmonary disease in Medicare beneficiaries residing in long-term care facilities.
    Simoni-Wastila L; Blanchette CM; Qian J; Yang HW; Zhao L; Zuckerman IH; Pak GH; Silver H; Dalal AA
    Am J Geriatr Pharmacother; 2009 Oct; 7(5):262-70. PubMed ID: 19948302
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Incentive and selection effects of Medigap insurance on inpatient care.
    Dardanoni V; Li Donni P
    J Health Econ; 2012 May; 31(3):457-70. PubMed ID: 22525715
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Senior prescription drug coverage: the state of the medigap markets in Massachusetts and New Hampshire.
    Miller M; Turnbull N
    Issue Brief (Mass Health Policy Forum); 2000; (7):1-34. PubMed ID: 12769116
    [No Abstract]   [Full Text] [Related]  

  • 28. Seasonal patterns in health care use and pharmaceutical claims for asthma prescriptions for preschool- and school-aged children.
    Van Dole KB; Swern AS; Newcomb K; Nelsen L
    Ann Allergy Asthma Immunol; 2009 Mar; 102(3):198-204. PubMed ID: 19354065
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Increasing costs of urinary incontinence among female Medicare beneficiaries.
    Anger JT; Saigal CS; Madison R; Joyce G; Litwin MS;
    J Urol; 2006 Jul; 176(1):247-51; discussion 251. PubMed ID: 16753411
    [TBL] [Abstract][Full Text] [Related]  

  • 30. US citizens' use of healthcare services rises.
    McCarthy M
    BMJ; 2014 Apr; 348():g2841. PubMed ID: 24742883
    [No Abstract]   [Full Text] [Related]  

  • 31. The epidemiology and pathophysiology of neurogenic bladder.
    Ginsberg D
    Am J Manag Care; 2013; 19(10 Suppl):s191-6. PubMed ID: 24495240
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Health insurance status, cost-related medication underuse, and outcomes among diabetes patients in three systems of care.
    Piette JD; Wagner TH; Potter MB; Schillinger D
    Med Care; 2004 Feb; 42(2):102-9. PubMed ID: 14734946
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of a medication copayment increase in veterans with schizophrenia.
    Zeber JE; Grazier KL; Valenstein M; Blow FC; Lantz PM
    Am J Manag Care; 2007 Jun; 13(6 Pt 2):335-46. PubMed ID: 17567234
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Urologic diseases in America project: urinary incontinence in males--demographics and economic burden.
    Stothers L; Thom D; Calhoun E
    J Urol; 2005 Apr; 173(4):1302-8. PubMed ID: 15758786
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Healthcare expenditure and resource utilization in patients with anaemia and chronic kidney disease: a retrospective claims database analysis.
    Wish J; Schulman K; Law A; Nassar G
    Kidney Blood Press Res; 2009; 32(2):110-8. PubMed ID: 19372704
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Overactive bladder: defining the disease.
    Wein AJ
    Am J Manag Care; 2000 Jul; 6(11 Suppl):S559-64; discussion S607-19. PubMed ID: 11183898
    [No Abstract]   [Full Text] [Related]  

  • 37. Safety and efficacy of percutaneous nephrolithotomy in patients with neurogenic bladder dysfunction.
    Rubenstein JN; Gonzalez CM; Blunt LW; Clemens JQ; Nadler RB
    Urology; 2004 Apr; 63(4):636-40. PubMed ID: 15072868
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Trends in health care expenditures, utilization, and health status among US adults with spine problems, 1997-2006.
    Martin BI; Turner JA; Mirza SK; Lee MJ; Comstock BA; Deyo RA
    Spine (Phila Pa 1976); 2009 Sep; 34(19):2077-84. PubMed ID: 19675510
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Health services utilization in the U.S. population by health insurance coverage.
    Garfinkel SA; Corder LS
    Natl Med Care Util Expend Surv B; 1986 Dec; (13):1-38. PubMed ID: 10304187
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neurogenic bladder dysfunction.
    Koff SA; Diokno AC; Lapides J
    Am Fam Physician; 1979 Feb; 19(2):100-9. PubMed ID: 760434
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.